SYNTASE
Mark Identification

SYNTASE

Serial Number

99421485

Filing Date

Sep 30, 2025

Trademark by

CRISPR THERAPEUTICS AG

Classification Information

Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders in the field of in vivo gene editing therapy; gene editing, namely, pharmaceutical research and development in the field of in vivo gene editing therapy; Research in the field of gene editing technology; Providing a gene editing platform for others to conduct pharmaceutical research and development in the field of in vivo gene editing therapy

Computer and Scientific